Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Fierce Biotech
After Enhertu: The slow hunt for next-gen HER2 breast cancer drugs
From dual-payload ADCs to bispecifics and radioligands, drugmakers are hunting for answers either after Enhertu progression or to replace it.
Angus Liu
Oct 28, 2026 9:00am
Lilly lifts guidance on back of another lucrative GLP-1 quarter
Oct 29, 2026 3:31pm
Lenz plans for major layoffs and a CEO switch in Q4
Oct 29, 2026 3:15pm
AZ enlists former teen TV star for biomarker testing push
Oct 29, 2026 2:41pm
Women 'still waiting' to trust healthcare institutions: report
Oct 29, 2026 2:30pm
BMS' Cobenfy underwhelms expectations in Q3 report
Oct 29, 2026 11:35am
More News
For Merck, 2027 is ‘another year of investment’
Oct 29, 2026 11:23am
Novartis refreshes myelofibrosis bid as Geron flops in ph. 3
Oct 29, 2026 8:15am
Kennedy eases up enforcement on compounding of 6 peptides
Oct 29, 2026 8:12am
Apellis buyout fuels Biogen's best quarter since 2020
Oct 28, 2026 11:54am